Leidos (LDOS)
NYSEIndustrialsInformation Technology ServicesSnapshot 2026-07-07
$108.59-0.12%
Close 2026-07-07 · 1-day change
Reading LDOS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LDOS free→NYSEIndustrialsInformation Technology ServicesSnapshot 2026-07-07
Reading LDOS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LDOS free→QuarterlyIQ Insights · LDOS
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 14 valuation methods, at three horizons. Current price $108.59. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $109 LDOS trades at 9.1× p/e, below its 29× p/e peer median. Our $173 fair value sits well above the price. We hold it with medium confidence: the peer anchor overstates how cheap it looks. Analysts target $110–$185. Not investment advice.
$110.00 – $185.00 (median $140.00) · 5 analysts · as of 2026-07-01
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $11.20/sh owner earnings.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2026-Q1, 2026-Q2, 2026-Q3, 2027-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $140.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $869.67 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $989.75 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $38.44 | — | — | TTM | high |
| graham number | 12M | $103.01 | — | — | TTM | high |
| Mgmt guidance | 12M | $330.67 | 29.3 | 11.30 | Mgmt | high |
| Peer EV/EBITDA | 12M | $239.61 | 15.0 | 18.99 | TTM | high |
| Peer P/FCF | 12M | $283.03 | 19.5 | 14.52 | TTM | high |
| Peer P/E | 12M | $348.81 | 29.3 | 11.92 | TTM | high |
| Peer P/S | 12M | $215.72 | 1.6 | 135.38 | TTM | high |
| PEG | 12M | $210.05 | 17.6 | 11.92 | TTM | high |
| residual income | 12M | $77.44 | — | — | TTM | high |
| Own P/E history | 12M | $163.48 | 13.7 | 11.92 | TTM | high |
| triangulated | 12M | $370.54 | 29.3 | 12.66 | Triangulated | high |
| Mgmt guidance | 3Y | $401.81 | 29.3 | 13.73 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $430.46 | 19.5 | 22.09 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $415.07 | 29.3 | 14.18 | Analyst | medium |
| Peer P/S | 3Y | $256.79 | 1.6 | 161.16 | guidance | medium |
| PEG | 3Y | $249.95 | 17.6 | 14.18 | Analyst | medium |
| Own P/E history | 3Y | $194.54 | 13.7 | 14.18 | Analyst | medium |
| Mgmt guidance | 5Y | $457.54 | 29.3 | 15.64 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $569.28 | 19.5 | 29.21 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $457.84 | 29.3 | 15.65 | Analyst | high |
| Peer P/S | 5Y | $283.25 | 1.6 | 177.76 | guidance | high |
| PEG | 5Y | $275.70 | 17.6 | 15.65 | Analyst | high |
| Own P/E history | 5Y | $214.59 | 13.7 | 15.65 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.